Literature DB >> 12490165

Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells.

Almut Kiesslich1, Anna von Mikecz, Peter Hemmerich.   

Abstract

Promyelocytic leukemia (PML) nuclear bodies constitute one class of intranuclear domains that may be directly involved in the expression of specific genes. Here we have analyzed the spatial relationship between PML bodies and sites of transcriptional activity by indirect immunofluorescence and confocal microscopy during the cell cycle. In unsynchronized mammalian cells approx 30% of PML bodies are spatially associated with transcription sites. These sites contain hyperphosphorylated RNA polymerase II, indicating active mRNA transcription tightly associated with the PML body. In G1 phase of the cell cycle more than 70% of PML bodies contain active transcription foci. A similarly high degree of colocalization (approx 80%) between PML bodies and sites of active transcription was also observed when the cells were exposed to interferon-gamma. We also show that the hypophosphorylated form of RNA polymerase II and the transcriptional coactivator CBP colocalize within PML bodies predominantly in G1. Our observations suggest that PML bodies may be recruited to nuclear sites of induced or up-regulated mRNA transcription where it may serve as a scaffold for factors involved in expression of specific genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490165     DOI: 10.1016/s1047-8477(02)00571-3

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  36 in total

Review 1.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

2.  Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.

Authors:  Cleo L Bishop; Michal Ramalho; Nachiket Nadkarni; Wing May Kong; Christopher F Higgins; Nina Krauzewicz
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

3.  Single-cell c-myc gene expression in relationship to nuclear domains.

Authors:  Eva Bártová; Andrea Harnicarová; Jana Krejcí; Ludek Strasák; Stanislav Kozubek
Journal:  Chromosome Res       Date:  2008-03-07       Impact factor: 5.239

4.  Segmentation of fluorescence microscopy images for quantitative analysis of cell nuclear architecture.

Authors:  Richard A Russell; Niall M Adams; David A Stephens; Elizabeth Batty; Kirsten Jensen; Paul S Freemont
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

5.  Assembly dynamics of PML nuclear bodies in living cells.

Authors:  Peter Brand; Thorsten Lenser; Peter Hemmerich
Journal:  PMC Biophys       Date:  2010-03-05

Review 6.  New Insights into the Functions of Nucleic Acids Controlled by Cellular Microenvironments.

Authors:  Saki Matsumoto; Naoki Sugimoto
Journal:  Top Curr Chem (Cham)       Date:  2021-03-30

7.  Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.

Authors:  Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

8.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  Functional complementation of human centromere protein A (CENP-A) by Cse4p from Saccharomyces cerevisiae.

Authors:  Gerhard Wieland; Sandra Orthaus; Sabine Ohndorf; Stephan Diekmann; Peter Hemmerich
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.